New Biomarker Candidates for Colon Cancer
Michael Schubert, PhD
New biomarker candidates may help determine which colon cancer patients are most likely to benefit from chemotherapy
A novel liquid biopsy technology leverages cell-free RNA “dark matter” to enhance cancer diagnosis
Easy-to-implement technology reduces the per-reaction cost of target capture by two to three orders of magnitude as compared to commercial solutions